Daniel Faga
Chief Executive Officer at ANAPTYSBIO, INC.
Net worth: 9 M $ as of 2024-03-30
Network origin in Daniel Faga first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 22 | |
Centerview Partners LLC
 Centerview Partners LLC Investment Banks/BrokersFinance Centerview Partners LLC is a registered broker/dealer headquartered in New York City. The firm was founded by Robert Pruzan in 2006 and is a subsidiary of Centerview Partners Advisory Holdings LLC. Centerview Partners provides brokerage services to companies, institutions and governments.
19
| Subsidiary | Investment Banks/Brokers | 19 |
| Subsidiary | Biotechnology | 12 | |
| Subsidiary | Biotechnology | 7 | |
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation.
6
| Holding Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel Faga via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member President | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor Investor Relations Contact | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree Graduate Degree | |
| AFFYMAX, INC. | Biotechnology | Chairman Chief Executive Officer | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree | |
| University of San Diego | College/University | Undergraduate Degree Masters Business Admin | |
| University of the Sciences in Philadelphia | College/University | Undergraduate Degree Graduate Degree | |
| Wesleyan University | College/University | Undergraduate Degree Undergraduate Degree | |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Georgetown University | College/University | Undergraduate Degree Undergraduate Degree | |
Huntsman Cancer Foundation
 Huntsman Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Huntsman Cancer Foundation provides cancer treatment services. It offes treatment and support and screening and prevention. The company was founded by Jon M. Huntsman Sr. and Karen Huntsman in 1995 and is headquartered in Salt Lake City, UT. | Miscellaneous Commercial Services | Director/Board Member | |
San Diego Venture Group
 San Diego Venture Group Financial ConglomeratesFinance San Diego Venture Group operates as a non-profit organization that engages in the funding of start up companies. it focuses on the provision of support to the venture capital eco-system. It serves entrepreneurs, venture capitalists, community leaders, and business advisors. The company was founded in 1986 and is headquartered in San Diego, CA. | Financial Conglomerates | Director/Board Member President | |
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | President Director of Finance/CFO | |
| PFENEX INC. | Biotechnology | Director/Board Member Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member | |
ImVax, Inc.
 ImVax, Inc. BiotechnologyHealth Technology ImVax, Inc. provides healthcare services. The company was founded in 2015 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member Chairman | |
| CENTURY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 48 |
| France | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 18 |
| Finance | 4 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 272 |
| Corporate Officer/Principal | 139 |
| Independent Dir/Board Member | 101 |
| Undergraduate Degree | 58 |
| Chief Executive Officer | 40 |
Most connected contacts
| Insiders | |
|---|---|
| James Topper | 49 |
| Michael Grey | 32 |
| Robert Perez | 31 |
| Magda Marquet | 30 |
| Dennis Fenton | 28 |
| Jak Knowles | 24 |
| John Schmid | 24 |
| Stephen Webster | 22 |
| John Orwin | 21 |
| David Meek | 18 |
| Hollings Renton | 17 |
| Shalini Sharp | 17 |
| Arjun Goyal | 16 |
| Laura Hamill | 15 |
| Thomas Ciulla | 15 |
- Stock Market
- Insiders
- Daniel Faga
- Company connections
